Interestingly, sphingolipid studies in PD have shown similarities with AD as ceramide levels were increased, Sphk1 activity was significantly reduced, and Sphk1/S1P signaling was disrupted, as reported in AD as well. The gene discussed is SPHK1; the disease is Alzheimer disease.